1. Acute vascular events as a possibly related adverse event of immunotherapy: a single-institute retrospective study. (October 2019) Authors: Bar, Jair; Markel, Gal; Gottfried, Teodor; Percik, Ruth; Leibowitz-Amit, Raya; Berger, Raanan; Golan, Talia; Daher, Sameh; Taliansky, Alisa; Dudnik, Elizabeth; Shulman, Katerina; Urban, Damien; Onn, Amir Journal: European journal of cancer Issue: Volume 120(2019) Page Start: 122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Chemoradiation followed by adjuvant durvalumab in stage III non–small cell lung cancer: Real‐world comparison of treatment outcomes to historical controls treated with chemoradiation alone. Issue 12 (11th May 2022) Authors: Saad, Akram; Goldstein, Jeffrey; Appel, Sarit; Daher, Sameh; Urban, Damien; Onn, Amir; Gantz‐Sorotsky, Hadas; Lobachov, Anastasiya; Gottfried, Teodor; Spieler, Benjamin; Bar, Jair Journal: Thoracic cancer Issue: Volume 13:Issue 12(2022) Page Start: 1763 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Driver mutation characteristics of phosphatidylinositol-4, 5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) in advanced non-small cell lung cancer. (April 2023) Authors: Daher, Sameh; Zer, Alona; Tschernichovsky, Roi; Yacobi, Rinat; Barshack, Iris; Tsabari, Shani; Rottenberg, Yakir; Zick, Aviad; Gottfried, Teodor; Lobachov, Anastasiya; Marom, Edith M.; Urban, Damien; Saad, Akram; Gantz-Sorotsky, Hadas; Onn, Amir; Bar, Jair Journal: Lung cancer Issue: Volume 178(2023) Page Start: 229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effectiveness and safety of nivolumab in advanced non-small cell lung cancer: The real-life data. (December 2018) Authors: Dudnik, Elizabeth; Moskovitz, Mor; Daher, Sameh; Shamai, Sivan; Hanovich, Ekaterina; Grubstein, Ahuva; Shochat, Tzippy; Wollner, Mira; Bar, Jair; Merimsky, Ofer; Zer, Alona; Goldstein, Daniel A.; Hammerman, Ariel; Cyjon, Arnold; Shechtman, Yelena; Abu-Amna, Mahmood; Flex, Dov; Roisman, Laila C.; ... Journal: Lung cancer Issue: Volume 126(2018) Page Start: 217 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ≥50%: real-world data. (1st January 2021) Authors: Dudnik, Elizabeth; Moskovitz, Mor; Rottenberg, Yakir; Lobachov, Anastasiya; Mandelboim, Rinat; Shochat, Tzippy; Urban, Damien; Wollner, Mira; Nechushtan, Hovav; Rotem, Ofer; Zer, Alona; Daher, Sameh; Bar, Jair Journal: Oncoimmunology Issue: Volume 10:Number 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Real-world experience with capmatinib in MET exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program. (June 2022) Authors: Illini, Oliver; Fabikan, Hannah; Swalduz, Aurélie; Vikström, Anders; Krenbek, Dagmar; Schumacher, Michael; Dudnik, Elizabeth; Studnicka, Michael; Öhman, Ronny; Wurm, Robert; Wannesson, Luciano; Peled, Nir; Kian, Waleed; Bar, Jair; Daher, Sameh; Addeo, Alfredo; Rotem, Ofer; Pall, Georg; Zer, Alona... Journal: Therapeutic advances in medical oncology Issue: Volume 14(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗